Balo’s disease, formally called Balo concentric sclerosis, is a rare and aggressive form of inflammatory brain disease closely related to multiple sclerosis but distinguished by a striking pattern on brain imaging: alternating rings of destroyed and preserved nerve insulation that look almost like a tree’s growth rings or the bullseye of a target.1PubMed Central. Balo Concentric Sclerosis: A Rare Variant of Multiple Sclerosis With Excellent Response to Early Steroid Treatment Named after the Hungarian neuropathologist József Baló, who described it in the 1920s, the disease was once considered almost uniformly fatal. That picture has changed considerably with modern imaging and treatment, though Balo’s remains one of the more dramatic and poorly understood conditions in neurology.
What the Brain Looks Like and Why It Matters
The hallmark of Balo’s disease is what clinicians see on an MRI: concentric rings, or lamellae, of tissue where the myelin sheath around nerve fibers has been destroyed, alternating with bands where myelin appears intact.2PubMed Central. Balo’s concentric sclerosis a rare variant of multiple sclerosis in a Nigerian adult male: A case report Myelin is the fatty insulation that allows electrical signals to travel quickly along nerve fibers. In ordinary multiple sclerosis, the immune system strips away myelin in irregular patches called plaques. In Balo’s disease, the destruction arranges itself into these highly organized concentric layers, sometimes spanning several centimeters across.
This pattern is not just visually unusual; it tells you something about how the disease spreads through the brain. One leading explanation holds that when the inflammatory process destroys myelin in one ring, it inadvertently triggers a protective response in the adjacent band of tissue. Nerve-insulating cells in that neighboring band begin expressing stress-response proteins associated with surviving low-oxygen conditions. This “preconditioning” temporarily shields them from the advancing damage. But the protection does not extend further out, so the next ring of tissue remains vulnerable. As the wave of inflammation continues outward, it hits unprotected tissue again, destroys it, preconditions the next ring, and so on, leaving behind the characteristic bullseye.3Oxford Academic (Brain). Establishing preconditions for Baló’s concentric sclerosis
A separate line of research has drawn a parallel to something from chemistry: Liesegang rings, the periodic banding patterns that form when certain chemical reactions spread through a gel. Using mathematical models based on the movement and signaling of immune cells, researchers have shown that a self-organizing process driven by immune cell migration can reproduce the concentric ring pattern seen in Balo’s lesions without needing any external template.4PLoS ONE. The Origins of Concentric Demyelination: Self-Organization in the Human Brain In other words, the rings emerge naturally from the way the immune system and brain tissue interact, not because some deeper structural feature of the brain is ring-shaped.
How It Differs From Typical Multiple Sclerosis
Although Balo’s disease is usually classified as a variant of MS, there are reasons to think it may be immunologically distinct. One of the strongest pieces of evidence involves oligoclonal bands, a laboratory marker that shows up in spinal fluid when the immune system is producing antibodies inside the central nervous system. In MS, these bands are present in at least 95 percent of patients and tend to stay positive for life. In Balo’s disease, the picture is reversed: a retrospective analysis of nearly 150 spinal fluid samples found that about two-thirds of Balo’s patients lacked oligoclonal bands entirely. Among those with the most convincing imaging features, the absence rate climbed to over 80 percent.5PubMed Central. Baló’s concentric sclerosis is immunologically distinct from multiple sclerosis: results from retrospective analysis of almost 150 lumbar punctures That is a large and statistically robust difference, and it suggests the immune attack in Balo’s disease may operate through a fundamentally different pathway than typical MS.
When pathologists examine Balo’s lesions under a microscope, they find a specific pattern of damage in which the myelin-producing cells themselves appear to be the primary target. All patients with available tissue in one pathology review showed this same pattern, one that involves oligodendrocyte death in active lesions.6PubMed Central. Clinical and Radiologic Features, Pathology, and Treatment of Baló Concentric Sclerosis Separately, researchers have found that the water-channel proteins AQP1 and AQP4 are lost within demyelinated Balo’s lesions, but patients do not carry the antibodies against those proteins that characterize neuromyelitis optica, another condition that can occasionally be confused with Balo’s.7PubMed Central. Antibody signatures in patients with histopathologically defined multiple sclerosis patterns This overlap-without-identity is part of what makes Balo’s disease so tricky to categorize: it shares features with MS, shares features with neuromyelitis optica, yet does not neatly fit into either box.
Symptoms and Who Gets It
Balo’s disease tends to show up in younger adults, often between the ages of 20 and 50, though cases have been reported across a wide age range. The symptoms depend entirely on where in the brain the lesion forms. Common presentations include progressive weakness on one side of the body, difficulty speaking or understanding language, headaches, muscle spasms, cognitive changes, and seizures.8Case Reports in Neurology. Baló Concentric Sclerosis Mimicking Encephalitis with Seizures and Progressive Aphasia in a 26-Year-Old Woman: A Challenging Diagnostic Dilemma In one published case, the primary presentation was seizures and progressive loss of the ability to speak, which initially led doctors to suspect viral encephalitis rather than a demyelinating disease.
This diagnostic confusion is a recurring theme. Because Balo’s lesions are often large and can produce swelling in surrounding tissue, the initial imaging appearance can mimic a brain tumor or an abscess. The clinical picture, a young adult with a rapidly worsening focal neurological deficit and a large ring-enhancing lesion on MRI, puts a long list of possibilities on the table. The concentric ring pattern, when clearly visible, is the giveaway, but it is not always obvious on the first scan or with standard imaging sequences.
Cognitive and behavioral changes also deserve mention. The disease can present as a subacute decline in thinking and behavior, sometimes evolving over days to weeks, which in younger patients can be mistaken for psychiatric illness before imaging reveals the true cause.9Medwave. Early diagnosis of Balo’s concentric sclerosis by diffusion tensor tractography: a case report and literature review In at least some patients, these cognitive deficits improve alongside the visible regression of the brain lesion on follow-up scans.10Clinical Neurology and Neurosurgery. Balo’s concentric sclerosis diagnosed intravitam on brain biopsy
Advanced Imaging Beyond Standard MRI
Standard MRI with T2-weighted sequences is usually enough to spot the concentric ring pattern, but several advanced techniques can add useful information, particularly when the diagnosis is uncertain or when doctors need to rule out a tumor.
Magnetic resonance spectroscopy (MRS), which measures the chemical composition of brain tissue without cutting into it, shows a characteristic profile in active Balo’s lesions: a drop in NAA (a marker of healthy nerve cells), a rise in choline (indicating membrane breakdown), and the appearance of lactate or lipid peaks that suggest tissue under severe metabolic stress.11Radiology Case Reports. Advanced neuroimaging in Balo’s concentric sclerosis: MRI, MRS, DTI, and ASL perfusion imaging over 1 year This pattern shares some overlap with aggressive brain tumors, but the degree of NAA loss tends to be less extreme than in high-grade gliomas, which can help tip the balance toward an inflammatory diagnosis.
Follow-up spectroscopy provides even more useful information. In serial studies, the choline peak and lactate signal tend to decrease over time as the active inflammation settles, while the NAA level may partially recover, reflecting some degree of nerve fiber repair or remyelination.12PubMed. Contribution of proton magnetic resonance spectroscopy to the diagnosis of Balo’s concentric sclerosis Similar trends have been confirmed in very young patients, where the metabolite patterns track from active demyelination through a phase of scarring and then partial recovery.13PubMed Central. Serial proton MR spectroscopy and diffusion tensor imaging in infantile Balo’s concentric sclerosis Diffusion tensor imaging, which maps the integrity of white-matter tracts, can sometimes reveal the concentric structure even before standard MRI sequences make the rings clearly visible, potentially speeding up diagnosis.
Treatment and the Shift Toward Better Outcomes
In its early medical literature, Balo’s disease was described almost exclusively from autopsy findings, which naturally created a picture of near-universal fatality. Modern imaging has completely rewritten this narrative by catching cases that would previously have gone unrecognized or been misdiagnosed as tumors, many of which turn out to recover well.
The first line of acute treatment is high-dose intravenous corticosteroids, the same approach used for severe MS relapses. In one well-documented case, a patient with progressive one-sided weakness whose disability score was severe (a 6 on the standard scale, meaning the person needed a walking aid) improved to near-normal function (a score of 1) within a month of starting steroid treatment.14PubMed Central. Balo Concentric Sclerosis: A Rare Variant of Multiple Sclerosis With Excellent Response to Early Steroid Treatment That kind of rapid turnaround is not guaranteed, however. Some patients are steroid-refractory: one reported case involving spinal cord involvement showed no benefit from steroids, and plasma exchange also failed to help. That patient was eventually stabilized with mitoxantrone, a more aggressive immunosuppressant, but remained significantly disabled.15PubMed. Spinal cord involvement in Balo’s concentric sclerosis
Spontaneous remission without any treatment has also been documented. At least one patient with a large lesion adjacent to the lateral ventricle showed spontaneous healing on serial MRI scans.16PubMed Central. Balo’s concentric sclerosis in a patient with spontaneous remission based on magnetic resonance imaging: A case report and review of literature The range of outcomes, from fatal to self-resolving, is one of the most confusing aspects of the disease and makes prognosis difficult for any individual patient.
Preventing Relapses With Long-Term Therapy
Beyond managing the initial attack, preventing future episodes is a major concern. Because Balo’s disease is so rare, no randomized controlled trials have compared disease-modifying treatments head to head. The best available evidence comes from retrospective case series, and the most recent data strongly favor one class of drugs.
A retrospective series found that patients treated with glatiramer acetate, one of the older MS drugs, had a high relapse rate: four out of six patients relapsed on it. Natalizumab, another established MS therapy, fared somewhat better but still saw relapses in half the patients treated. By contrast, all ten patients treated with anti-CD20 therapies (primarily ocrelizumab, with two patients on rituximab) remained relapse-free over a median follow-up of more than five years.17PubMed. Baló’s concentric sclerosis: A retrospective case series Anti-CD20 drugs work by depleting a specific population of immune cells (B cells), which suggests that B cells play a central role in driving the disease, a finding consistent with the broader shift in MS treatment toward B-cell-targeting therapies.
These are small numbers, and it is worth emphasizing that a case series of ten people is not the same as a large clinical trial. Still, the contrast between a 100 percent relapse-free rate on anti-CD20 therapy and the poor performance of older drugs is striking enough to shape treatment decisions in practice, especially given the absence of better data.
Balo’s Disease in Children
Although typically thought of as an adult disease, Balo’s concentric sclerosis does occur in children, and the pediatric experience adds some interesting wrinkles. A case series from one demyelinating disease center identified three pediatric patients with Balo-like lesions out of a cohort of 134 children with demyelinating diseases, a prevalence of about 2.2 percent. None of those cases were fatal, and the authors suggested that the developing immune and nervous systems may handle the disease differently than adult tissue does.18PubMed. Balo concentric sclerosis in children: a case series
The imaging in children looks similar to the adult version: concentric hyperintense rings on T2-weighted MRI, usually round or ovoid. But one study of pediatric patients found that four out of the children also had typical MS plaques alongside their Balo lesions, and seven had oligoclonal bands in their spinal fluid.19PubMed. Magnetic Resonance Characteristics of Baló Concentric Sclerosis in Children That stands in contrast to the adult literature, where the absence of oligoclonal bands is a defining feature. It raises the possibility that Balo-pattern lesions in children may overlap more with conventional MS than they do in adults, or that the disease represents a broader spectrum where the concentric pattern is one manifestation rather than a completely separate entity.
Long-term follow-up data in children remain sparse. One series tracking three juvenile patients for two to six years reported sustained benefit from standard MS disease-modifying therapies.20L.O. Badalyan Neurological Journal. Baló’s concentric sclerosis in the pediatric population: literature review and analysis of clinical cases in the context of follow up observation Whether children ultimately need the same aggressive anti-CD20 approach that appears effective in adults is an open question that no study has yet answered directly.
Why Some Brain Biopsies Still Happen
Given how distinctive the imaging can be, it may seem surprising that anyone would undergo a brain biopsy for suspected Balo’s disease. But the reality is that the concentric ring pattern is not always fully formed at the time of the first scan, and even when it is, the combination of a large, ring-enhancing lesion with surrounding swelling in a young adult can be nearly impossible to distinguish from a brain tumor on imaging alone. A high-grade glioma, a brain abscess, or lymphoma can all produce ring-shaped enhancement on MRI.
In practice, biopsy is sometimes performed when the clinical picture is ambiguous and the stakes of getting the diagnosis wrong are high. Treating an inflammatory lesion with chemotherapy, or treating a tumor with steroids while delaying surgery, could both be disastrous. Spectroscopy and other advanced techniques can narrow the differential, but they are not available everywhere and are not always definitive. The good news is that when a biopsy does confirm Balo’s disease, the tissue findings consistently show the same pattern of oligodendrocyte-targeted damage, which helps explain why the disease responds to immunosuppression when caught in time.21PubMed Central. Clinical and Radiologic Features, Pathology, and Treatment of Baló Concentric Sclerosis
The Question of Whether It Is Really a Separate Disease
Neurologists have argued for decades about whether Balo’s disease is truly its own entity or simply an unusual pattern that MS can produce under certain circumstances. The evidence cuts both ways. On the side of separation: the consistent absence of oligoclonal bands in adults, the specific tissue-level pattern of damage, the self-organizing ring formation that has no parallel in ordinary MS plaques, and the dramatically different response to certain disease-modifying drugs all suggest something immunologically distinct is going on.22PubMed Central. Baló’s concentric sclerosis is immunologically distinct from multiple sclerosis: results from retrospective analysis of almost 150 lumbar punctures
On the other hand, some patients who initially present with Balo-type lesions go on to develop a clinical course indistinguishable from relapsing-remitting MS, and pediatric cases in particular seem to blur the boundary. Some patients have both classic MS plaques and Balo rings coexisting in the same brain.23PubMed. Magnetic Resonance Characteristics of Baló Concentric Sclerosis in Children The honest answer is that the field has not settled this question, and the practical implications are real. If Balo’s disease is truly separate from MS, it may need its own diagnostic criteria, its own treatment algorithms, and its own prognostic framework. If it is simply one end of the MS spectrum, the current practice of applying MS treatments with some dose adjustments may be adequate. The recent data on anti-CD20 superiority over older MS drugs leans toward Balo’s requiring a more targeted approach, but the sample sizes remain too small for anyone to declare the debate closed.